CINXE.COM

<!DOCTYPE html><html lang="en-US"><head><title>Just a moment...</title><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta http-equiv="X-UA-Compatible" content="IE=Edge"><meta name="robots" content="noindex,nofollow"><meta name="viewport" content="width=device-width,initial-scale=1"><style>*{box-sizing:border-box;margin:0;padding:0}html{line-height:1.15;-webkit-text-size-adjust:100%;color:#313131;font-family:system-ui,-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Helvetica Neue,Arial,Noto Sans,sans-serif,Apple Color Emoji,Segoe UI Emoji,Segoe UI Symbol,Noto Color Emoji}body{display:flex;flex-direction:column;height:100vh;min-height:100vh}.main-content{margin:8rem auto;max-width:60rem;padding-left:1.5rem}@media (width <= 720px){.main-content{margin-top:4rem}}.h2{font-size:1.5rem;font-weight:500;line-height:2.25rem}@media (width <= 720px){.h2{font-size:1.25rem;line-height:1.5rem}}#challenge-error-text{background-image:url(data:image/svg+xml;base64,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);background-repeat:no-repeat;background-size:contain;padding-left:34px}@media (prefers-color-scheme:dark){body{background-color:#222;color:#d9d9d9}}</style><meta http-equiv="refresh" content="390"></head><body class="no-js"><div class="main-wrapper" role="main"><div class="main-content"><noscript><div class="h2"><span id="challenge-error-text">Enable JavaScript and cookies to continue</span></div></noscript></div></div><script>(function(){window._cf_chl_opt={cvId: '3',cZone: "www.pfizer.com",cType: 'managed',cRay: '8e8ffdcacf164a77',cH: 'eqqQ6rkCC9vxK2Cuv4I_vprXGvIMl4U9EKH8GcBytu0-1732688206-1.2.1.1-amEoFhzjF6.inwbXJmcUziUCQJHckQIvAp5w5SMPTcZVmX2voWQHdOOpURufnLuX',cUPMDTk: "\/news\/articles\/what_are_biosimilars_and_how_do_they_expand_treatment_options_for_patients?__cf_chl_tk=bq.yj2nmxg_t1VFtwwiZLeM.fYSLnQh7I4EstRfa6fU-1732688206-1.0.1.1-K8mkQtdtcjI6KDJoXLqSLiAXVHCBz6SFfBLBFai_p7o",cFPWv: 'b',cITimeS: '1732688206',cTTimeMs: '1000',cMTimeMs: '390000',cTplC: 0,cTplV: 5,cTplB: 'cf',cK: "",fa: "\/news\/articles\/what_are_biosimilars_and_how_do_they_expand_treatment_options_for_patients?__cf_chl_f_tk=bq.yj2nmxg_t1VFtwwiZLeM.fYSLnQh7I4EstRfa6fU-1732688206-1.0.1.1-K8mkQtdtcjI6KDJoXLqSLiAXVHCBz6SFfBLBFai_p7o",md: "tvq2K2HdEeXesU5zsSULcVuhUg5g5uNzWLCCkEKU6Z0-1732688206-1.2.1.1-AE7vC0YjaJuK3N34jrOxkS5VbNk3qqhQkJOzSPoSfKEyWYMewTz5y6H5Nj98U7WbAcYW.hEPxSelv.7T5JiUuQlALySr_uLHHmRzXcdqNfHs_Mb6S9Jv5BH7M6cEZZk1gcCwm9TBkk3860.sECXZz3NScPiIhmlDFXU_2FkY2FML86ht9X5a29.xamVLuXJhm8Urpf52h.NLthxioNsZNxdw8nXnYFiYY4eZOfCDUs_SkaaJdgHjWuga.j7SeIFV76qBNXovNZBILTzJEaveRHOyTxhqWyMVYMckCljqxEBQ3KHCbPEVtTYNtVWuGWU.ZbOi8XxDLOQJo0g8AAVRyiG7arqRiJtGfuXHiTepzMjPLynkfYpczV7q0KDN82BfX6Geb6qF.FYRk78TLsL5cKQeMnC7gt0t2D.Qi3tVVlcpmCNR.NfUR.c4_YaxIBy.WdGjQSUMi865_vW5H33rZens2.Asz5Opns3Dj8tqZr9x.hIg4zFaRNoV7W.wAkRj7_VlkSOTHb0RDaq48u7QkYZUevJVcI43zxmuthAdQ2z8dE0pBirDtvCuo8nwWqBIr0QMMK.oLXxlZPZ8FYo30Xf8dkom4axh8sPtq_NTxVdvS2Kwy9XkIRfIe4BWTJI5njifWCyRCv8PlSBsrqWxTaigTh33diNqz_QGN60vhqYMXGvbuT4sYMBNVqWkToV_YMNbPRvugQHIM1cGbcvafFt3AlzpVXHzI3x.wr2V9.aDSBN.zjaAKWTyrBXL.Gy6.rOg4IdT1ZccL8BAFbPGxW8YZu_gqDRiHyl03LT2nh2yxQvr3HGYb_IHt339RiwgwsiAkcOyFX9CGuDPId69S.8GyDxqkm_QYMRtEUMVo4ZFu5Voe4SccvuiX1B4X8v5E1qk3JO2QR31KYkLkYHvqJfTT7kAVDzZeYAuHyoZtDrmzPt0WhYCQREtm9BMpERgf8A.a1rB.GsStMabuM6kZ.XLXJcKnhgOA7lyh2o3_Nb8F.f5I6UKXS9fiZQuE9eHqGeacA1bI.rI1iuv9hw66cxpfH.Ow0PSbD5G5AjGBTKCJ2aBrmgGDduOhDQgaWSJfzaDqFEeS9gN79ndvSTRQxLmS4CHmKcp0gMpxbQ.tmG8ukriQhItKK2McW9w3U0L.uvJaS1vBQDwL3U9TlxYTj66Sk7I9M1X6MNCmd80yJSeL5Liden4NCmyY6jN5rEeBFRozEJKFqVzGcUYmYRqjrO1yyPtGHYY0_LQWrU.R_3rDKIRVfgnU_s0y2.T4qQ8mWxqwfy95XPNZCo_61oWt5Yo0_1bvIaS4bZdPeCWKUrE79C8ppraR0GJ9lLnfT8jfa7ayNzAGY5EOqwCaRtniRRADdhlRGcfj99jIcPxr_JoQP2xH1tcE8Xop8LaOzU8ADYDlijA5AblOfq1kuD5zUVyynhmtQ3Y0sewyh.kxJFM6cuiVw1qPswHaIakmCfSIAOl_n5ec.GY39_fv05TT1I4ezmdjWexs72uP.8wCVbXhK50xBbFIa4qjrUbXHoIWmgFesq7c4D00vt2ooUV0f6Nh0kej2kGSR.sPRy6pnLPru823kJuN0Wv4wZ8HVU_IgVc_x58Ny3wHeEq7tSQUBLoLdvlgzozyAw0jNEFPOGAzsW0gdt4BjYRKxkpxcqwub_zxbwQkUiI20hwf0ARwSxBlDR2upQiKt6w2uFHDDqZf0xw4tRmNlpBh_m8lUfsKnwI0OScX8XJg7gLsZhmBzicXQes4ws3Ibk51zbYljSLbHwTV08P_k2sxeqGqjEL_C1oQlt5AEZIshIdRKOzV3ERscwxZfL6qGUOO9TQBAjVCg3IX33zV5JM7bFyw9lOpDSi8biVrYHmx7dzYYsiIwdd6NztU__lQnn5BxapTyYvcVDu8UcK.idDr2_.mlvBaJKc254v1bhAWWXzZWy3CvP9tRrO8DaFN_ykd5s65xeS.5uNNqyxmkLFW78u2vechnNISgRBtHkD7EVEpZC7wYaiqQqWEdMZwNDOojQuNSeroCaAC2bpf33d7U_p9uXJMiBLXbOU37nStIGfZhSvg0MTUpc.4hACs0B7ux90udq9RALlZ8vbhxhRcp_ziwOFT5aU_2s2krH_CEuGqPtGOshOnsAda1FX6_07N7ZkdU0BLG_VASWxHXFScGyMFGBfGs4eAgMyLONz5UzeEFQQAdTbwSwnu3A_DjREcCFPOHxQ1KN5v77EUpjoGeuDSdU_kyS1jsoX.s2Juc6JWvkd0r6.6mp9.VhV.40x_EKS9jB8wZ.AT.TyeBQFXBtgnLxm4x0i7PJX7QGoHQ8ciQ8479eWIiI6gTJFRUdloD2YbkYjOfFitfzEyw6B50U0ayRiWJoVAldq2FdDRbHMf7w9Tpv6NN54wqFPUjH4ZzejbQZL6dj6bUiqmRA8gxPEBA24eaMRBae7R57GPRMhBnB2KlJbQcaED_dvAPsvfVIwHPXeWi.VpAKkiB7X.up8ImBvtW3WvXabxdVAjqqMfnKA_OWm9DhIzOCuYsvVE.p4bP56GQGY0kbG4QLcAatKhGeLxHvmUj4vXAB4GVqpJm3IU8KoE4RW8oXqkZcprR3GLk3DTgMIIWHImfp.DoeEuluRfXpmj7kq7o7SEqe4Eh0avV3UCAyjQ1hVoKU9L4AMTW7xNWNDVLceF5Z4dJwamXgAkAgjJi01LMEHytmcCMOA55Td1.l5Rv68ninf55W71tPiRuY1zn_lIEbxah5JIA.hEqYdq.fHN__C4.IwTW5_x_M6O2V4MIs7wElo2L1NwYLu5zo586QcsAe1LA8ia0b6HF0tct1M_JiHHwAibxEOOkpYv1mNrA4lUv3U2jer2hPRnipSZxa.Y6VkImHer8W8NWefQ9oPoYStdE0Nm.OH5T5caYPwzbl.mq7Nn4AtmYl4RpYKNPSS_ChaodtJBEuXqmNv0FnF4LrhqMNAaRZVSnb70T87f4RLS5mOD8kt2uw",mdrd: "zXjRmypnso_41ETMmXH33bQIlE5lVMw7WIWcR5DOWJo-1732688206-1.2.1.1-XMVUN6TcVs0VrLF8hOMYdEIdJTDFcDsgu0HFXtwsGrOQt1AdaBtouWa0BO9EvtDxXU0emi9h4tjpak7Yiqmf7GkezQ4tHmfizvgMdoL_Ao4_GeOrji7PFKQXj_MayinL7Ju5_CpCbPw3_YVYuE.TUDyZllGIjxYMwOzXvY_l9OnkugzLpNHUqhUOOcSX8H6R9.B0Azyquhf8VAhYTJpNKd9rWYD4Dbc.CAiImBp1vo23fs3MA5KNcQ99iOlGRKfSpGZMaUumoKKKFEHZsFVsDu0nqqXfhoiN2NRvgksGPB7J71DBGjrzOoR7sZPgYoKdQ3XDDgbAC23nJ42TbO196uo9BvgZxJQOfmUgkAoL9rTXDMutsG_mP3yIUW.pLX.qyqrrlutPlbIGNLLSfa_2E68PUUiiMnKTk8zXWl6mxOTDQoMkQDd6AIa8KwcQMnkKlaK4YFS0z2KA7ODuTKoobNb2c7b3hTMEfVsZhQAIC1CPt_8cxxnq_SWGVJJV3BZKYWj34hxrr4yT1UNU2RsAF3KhAUW44sISNQJbjwKUV9d7Ce2441kEQwDLFf0xoqrOOY7l6iRkJYRbaoy.2Sjp7uXMoqwsfY4yqQgzZ4o0xU8zoXZA8XG6gd90wvIMBcGe05j4m1Rv9umNLmB13ihrGtlCFFGvcgd4maUsOoo2.WdeG5KO5OF_UR4tm.lgUC3DeS9sqdZqlGo7j6pNBnaZ1FPtKTE1e2EmwQbmycw3Z7TNBIf6RWJ7lUQxxIy7y9Gu7cMBFq0jVj.atvD2LEqBzk33jYtpwG_Riyefb0iUG6bOljRVhv8j4iu55s_aEvWlE3W2mQhwE4IbRAXhYe6ILA4A9zU1bLmdho40ycPAPE8Mg8BW7RmwOWlSs3WseTHY5i.avfNLnTSBLXJKjsKvARxCar7Bg7kDcacJWhvZ4BVN9Sppzad7xtmjvggS1oxrRZ3AXLPRcJP85wFkwL2THnlO75tyt4VIfvbq8AtgHnhoYuH3icQi_NhwxqeqeGNOjUwrgNgfCQTi.GE3GHh7rsIIGo3lze04irfqpKJYGkDwbt8xJN3A3_Ho1MvGcBBjD5OR8MNSilCs1ygyFGjWP8eRYQE2w54Oze71GlUOEkIyPCvhzEwYjqzD50qO0FC__HrZUBBRRMyITqUpmaCuwBASFs2o.Uz47_Amtmmwiitk_Pjh3hTbetilA2vMinI7.4Bz2stC85ogHjpGHX6ZXYBvczqxHT7DM4QUkWIliAWMdf7NgqCk23Zy6hen1V1.4doLNMDTKeRlantzHCgA5h6NLBZHZJr9DrIKEl3shduituiPJJugwhioxa2aCWFYk5Km4QKytvc6mmBf2wmJXzdKkEP0DmYDyUv5efuIL_Ayy6JmPVo1Gcl3Ny6bxZGujxElAxvaE2ubJUQH2nCVmCNi3TDbIRmDD2YIalQJFJ2V_2RSmVY9mLkf9755tFzAyPTKPk1L5rbUHh7MfWYgYNUJq9i_kKJo4JoT6B3ErsarwnHnWX3BZXr6_5IRUYCLTe5bHM6SDwa1ezRM1OZlwyjt4FdkSnHs33kzuac527nh6ViO1GF_BDkOksMzc3UYDxY7sp32264mAYyYPizZT1YKbUehkIuK5uLk_UR6U42zPm2G3Zn10.0hEQZnxYlCn4axegbELk1oLcAY.A_dusldkpe3ZNfFWePly547yizGhaoNwupbrmRh_Sw9jYF47SUIMdCSxY6QtWTwpqja4Vohx0Jez0zuGvUPX.6cDgdVqP_B19EP7hMi.4vZ1c19a5jSJ.SN7mk5afugHIFpiJ0K8q2us9yyA1npjhK4_6JpDq02Pl.O8eK4REFmat4mAUBEngBvSTNMm4ohsmnqCNYjHdpJbfLjSl.ciaX7m8k5Caa3b0BU4aTZ_vsKih_F7JYYc.99YLRF.8OhR5CmD6O_Bwr0rxBtCnYWZMVIjraihiSjHGzkvHWefDBiEdi2"};var cpo = document.createElement('script');cpo.src = '/cdn-cgi/challenge-platform/h/b/orchestrate/chl_page/v1?ray=8e8ffdcacf164a77';window._cf_chl_opt.cOgUHash = location.hash === '' && location.href.indexOf('#') !== -1 ? '#' : location.hash;window._cf_chl_opt.cOgUQuery = location.search === '' && location.href.slice(0, location.href.length - window._cf_chl_opt.cOgUHash.length).indexOf('?') !== -1 ? '?' : location.search;if (window.history && window.history.replaceState) {var ogU = location.pathname + window._cf_chl_opt.cOgUQuery + window._cf_chl_opt.cOgUHash;history.replaceState(null, null, "\/news\/articles\/what_are_biosimilars_and_how_do_they_expand_treatment_options_for_patients?__cf_chl_rt_tk=bq.yj2nmxg_t1VFtwwiZLeM.fYSLnQh7I4EstRfa6fU-1732688206-1.0.1.1-K8mkQtdtcjI6KDJoXLqSLiAXVHCBz6SFfBLBFai_p7o" + window._cf_chl_opt.cOgUHash);cpo.onload = function() {history.replaceState(null, null, ogU);}}document.getElementsByTagName('head')[0].appendChild(cpo);}());</script></body></html>